GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Total Stockholders Equity

Incanthera (AQSE:INC) Total Stockholders Equity : £-0.67 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Total Stockholders Equity?

Incanthera's Total Stockholders Equity for the quarter that ended in Sep. 2023 was £-0.67 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Incanthera's Book Value per Share for the quarter that ended in Sep. 2023 was £-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Incanthera's Debt-to-Equity for the quarter that ended in Sep. 2023 was -0.29.


Incanthera Total Stockholders Equity Historical Data

The historical data trend for Incanthera's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Total Stockholders Equity Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Total Stockholders Equity
1.21 1.69 0.83 -0.21

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Stockholders Equity Get a 7-Day Free Trial 1.13 0.83 0.43 -0.21 -0.67

Incanthera  (AQSE:INC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Incanthera's Book Value per Share for the quarter that ended in Sep. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Incanthera's Debt-to-Equity for the quarter that ended in Sep. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Incanthera's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines